451 related articles for article (PubMed ID: 30560718)
21. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
Griffin A; Brito JP; Bahl M; Hoang JK
Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
[TBL] [Abstract][Full Text] [Related]
22. Active surveillance of low-risk papillary thyroid cancer: A meta-analysis.
Saravana-Bawan B; Bajwa A; Paterson J; McMullen T
Surgery; 2020 Jan; 167(1):46-55. PubMed ID: 31526581
[TBL] [Abstract][Full Text] [Related]
23. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
[No Abstract] [Full Text] [Related]
24. Age-Dependent Clinicopathological Characteristics of Patients with T1b Papillary Thyroid Carcinoma: Implications for the Possibility of Active Surveillance.
Won HR; Jeon E; Heo DB; Chang JW; Shong M; Kim JR; Ko H; Kang YE; Yi HS; Lee JH; Joung KH; Kim JM; Lee Y; Kim SW; Jeong YJ; Ji YB; Tae K; Koo BS;
Ann Surg Oncol; 2023 Apr; 30(4):2246-2253. PubMed ID: 36581723
[TBL] [Abstract][Full Text] [Related]
25. A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Yoannidis T; Rotstein L; Gullane PJ; Gilbert RW; Pasternak JD; Brown DH; Eskander A; Almeida JR; Irish JC; Higgins K; Enepekides DJ; Monteiro E; Banerjee A; Shah M; Gooden E; Zahedi A; Korman M; Ezzat S; Jones JM; Rac VE; Tomlinson G; Stanimirovic A; Gafni A; Baxter NN; Goldstein DP
Thyroid; 2020 Jul; 30(7):999-1007. PubMed ID: 32126932
[No Abstract] [Full Text] [Related]
26. Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study.
Cao XJ; Liu J; Zhu YL; Qi L; Liu G; Wang HL; Wang ZH; Zhou Y; He JF; Guo JQ; Shi LL; Jian M; Shataer A; Yan GZ; Zhao ZL; Wei Y; Peng LL; Li Y; Che Y; Wang SR; Yu MA
J Clin Endocrinol Metab; 2021 Jan; 106(2):e573-e581. PubMed ID: 33107573
[TBL] [Abstract][Full Text] [Related]
27. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
28. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America.
Smulever A; Pitoia F
Arch Endocrinol Metab; 2019; 63(5):462-469. PubMed ID: 31482955
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes of radiofrequency ablation for solitary T1aN0M0 versus T1bN0M0 papillary thyroid carcinoma: a propensity-matched cohort study.
Tong M; Wang L; Gai Z; Zhu Y; Che Y
Int J Hyperthermia; 2023; 40(1):2257908. PubMed ID: 37848402
[TBL] [Abstract][Full Text] [Related]
30. Thyroid Cancer Treatment Choice: A Pilot Study of a Tool to Facilitate Conversations with Patients with Papillary Microcarcinomas Considering Treatment Options.
Brito JP; Moon JH; Zeuren R; Kong SH; Kim YG; Iñiguez-Ariza NM; Choi JY; Lee KE; Kim JH; Hargraves I; Bernet V; Montori VM; Park YJ; Tuttle RM
Thyroid; 2018 Oct; 28(10):1325-1331. PubMed ID: 29905089
[TBL] [Abstract][Full Text] [Related]
31. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.
Ito Y; Miyauchi A; Oda H
Eur J Surg Oncol; 2018 Mar; 44(3):307-315. PubMed ID: 28343733
[TBL] [Abstract][Full Text] [Related]
32. Active surveillance of low-risk papillary thyroid microcarcinoma.
Sugitani I
Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101630. PubMed ID: 35256266
[TBL] [Abstract][Full Text] [Related]
33. Active Surveillance as First-Line Management of Papillary Microcarcinoma.
Ito Y; Miyauchi A
Annu Rev Med; 2019 Jan; 70():369-379. PubMed ID: 30230964
[TBL] [Abstract][Full Text] [Related]
34. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
[TBL] [Abstract][Full Text] [Related]
35. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: A comparative study.
Xiao J; Zhang Y; Zhang M; Lan Y; Yan L; Luo Y; Tang J
Clin Endocrinol (Oxf); 2021 Apr; 94(4):684-691. PubMed ID: 33128786
[TBL] [Abstract][Full Text] [Related]
36. Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center.
Molinaro E; Campopiano MC; Pieruzzi L; Matrone A; Agate L; Bottici V; Viola D; Cappagli V; Valerio L; Giani C; Puleo L; Lorusso L; Piaggi P; Torregrossa L; Basolo F; Vitti P; Tuttle RM; Elisei R
J Clin Endocrinol Metab; 2020 Mar; 105(3):e172-80. PubMed ID: 31652318
[TBL] [Abstract][Full Text] [Related]
37. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
Forleo R; Grani G; Alfò M; Zilioli V; Giubbini R; Zatelli MC; Gagliardi I; Piovesan A; Ragni A; Morelli S; Puxeddu E; Pagano L; Deandrea M; Ceresini G; Torlontano M; Puligheddu B; Antonelli A; Centanni M; Fugazzola L; Spiazzi G; Monti S; Rossetto R; Monzani F; Tallini G; Crescenzi A; Sparano C; Bruno R; Repaci A; Tumino D; Pezzullo L; Lombardi CP; Ferraro Petrillo U; Filetti S; Durante C; Castagna MG
Thyroid; 2021 Dec; 31(12):1814-1821. PubMed ID: 34541894
[No Abstract] [Full Text] [Related]
38. A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Gullane PJ; Monteiro E; Gooden E; Brown DH; Eskander A; Zahedi A; Chung J; Su J; Xu W; Ihekire O; Jones JM; Gafni A; Baxter NN; Goldstein DP;
Thyroid; 2022 Mar; 32(3):255-262. PubMed ID: 35019770
[No Abstract] [Full Text] [Related]
39. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
McDow AD; Roman BR; Saucke MC; Jensen CB; Zaborek N; Jennings JL; Davies L; Brito JP; Pitt SC
Am J Surg; 2021 Jul; 222(1):111-118. PubMed ID: 33248684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]